The screening and assessment of the neoadjuvant chemotherapy for the ovarian cancer
10.11904/j.issn.1002-3070.2014.06.015
- VernacularTitle:卵巢癌术前新辅助化疗筛选与评估的展望
- Author:
Yulin SONG
;
Jing WANG
- Publication Type:Journal Article
- Keywords:
Advanced ovarian cancer;
Neoadjuvant chemotherapy;
Assessment;
Screening criteria
- From:
Practical Oncology Journal
2014;(6):553-556
- CountryChina
- Language:Chinese
-
Abstract:
Ovarian cancer is the highest death rate of gynecologic malignant tumor .Currently,people rec-ognize standard treatment for ovarian cancer was that reduction -Tumor cells of platinum based chemotherapy af-ter surgery.But for those patients who have developed into advanced cancer that cannot be operated the surgeries directly,the application of preoperative Neoadjuvant chemotherapy ( NACT) does have the superiority .which is recognized by the majority of clinical doctors ,and has been widely used in the treatment of advanced malignant tumor.It is worthy to discussing which part of patients should choose the initial treatment of Neoadjuvant chemo -therapy,rather than a direct treatment of destroying tumor cells .This article is summarizing the empirical cases based on related research ,in order to help clinicians to make a decision on the treatment of ovarian cancer .
